Skip to main content

Table 1 Children with symptomatic urolithiasis treated in both institutes in a period between 2014 to 2017

From: Guideline-adherence in the treatment of symptomatic urolithiasis in children and adolescents in southwestern Germany

N

Comorbidities

Age-range at presentation (a)

Affected side (L/R)

Stone position, size, density, hydronephrosis, underlying metabolic condition

Primary Treatment

Guideline Recommendation

Secondary Treatment

1

Osteogenesis imperfecta

adolescent

L

distal ureter, 3 stones: 3, 4, 6 mm, 50 HU, II° HN

conservative

conservative

0

2

type 2 diabetes, adiposity, hypothyreosis

adolescent

R

renal pelvis: 17 mm, 350 HU

SWL

SWL

1 (SWL)

3

premature infant, 26 + 2 week of gestation, twin I

toddler

R

renal pelvis: 12 mm, III° HN

presenting SWL

SWL

1 (SWL)

4

adiposity

adolescent

L

ureteral ostium: 2 mm

conservative

conservative

0

5

–

school-age

L

lower calix: 7 mm, III° HN, uric acid stones

chemolitholysis

chemolitholysis

1 (ureteral stent)

6

–

adolescent

L

ureteral ostium: 3 mm, 740 HU, II° HN

conservative

conservative

0

7

concurrent UPJO

toddler

L

stag-horn calculus: 20 mm, II° HN, struvit stone

Pyelolithotomy plus simultaneous pyeloplasty

PCNL

0

8

–

adolescent

L

distal ureter: 7 mm, II° HN

conservative

conservative

0

9

asthma

school-age

R

distal Ureter: 8 mm, II° HN

URS

URS

0

10

indeterminate colitis

adolescent

L

distal ureter: 5 mm, I° HN, rupture of renal fornix

prestenting flexible URS

URS

0

11

asthma

adolescent

L

proximal ureter: 5 mm, 210 HU, I° HN

conservative

SWL

1 (URS)

12

lactose intolerance

adolescent

L

proximal ureter: 3 mm, 460 HU, II° HN

SWL

SWL

0

13

iron deficiency anemia

toddler

L

renal pelvis: 8 mm, III° HN, type II primary hyperoxaluria

SWL

SWL

2 (URS)

14

–

infant

L

lower and middle calix: 6 mm each, cystinuria

prestenting flexible URS

URS

1 (URS)

15

depression, suspected developmental personality disorder

adolescent

L

proximal ureter: 4 mm, II° HN

conservative

SWL

0

16

major beta-thalassemia, S.p. bone marrow- and umbilical cord transplantation 12/2012

adolescent

R

distal ureter: 6 mm, II° HN

SWL

URS

0

17

–

school-age

R

ureteral ostium: 3 mm

conservative

conservative

0

18

right ureteral duplication, left dysplastic kidney

toddler

R

lower calix: 8 mm

prestenting flexible URS

SWL

0

19

–

school-age

L

lower calix: 10 mm, middle and upper calyxes: 5 mm each, III° HN

prestenting SWL

SWL

0

20

premature infant, 24 week of gestation short bowel syndrome

pre-school

R and L

R lower calix: 9 mm L renal pelvis: 20 mm, IV° HN (MAG3 scintigraphy: split function 89%: 11% R: L)

R presenting, URS L pyelolithotomy

R SWL L PCNL

2 (R SWL, L nephrectomy planned, split function 0%)

21

–

pre-school

L

renal pelvis: 15 mm, II° HN

prestenting SWL

SWL

2 (SWL, URS)

22

–

school-age

R

renal pelvis: 18 mm, II° HN

presenting SWL

SWL

4 (2 x SWL, 2 x URS)

23

–

school-age

L

renal pelvis: 4 mm lower calix 2 stones, 5 mm each cystinuria

SWL

URS

1 (SWL)

24

–

toddler

L

renal pelvis: 16 mm, II° HN

prestenting SWL

SWL

1 (SWL)

  1. HU Hounsfield units, HN Hydronephrosis, URS Ureterorenoscopy, SWL Shock-wave lithotripsy, PCNL Percutaneous nephrolithotomy, L/R L left, R Right, UPJO Ureteropelvic junction obstruction, aage-ranges at presentation: infant < 1 years, toddler 1–3 years, pre-school children 3–6 years, school-age children 6–14 years, adolescents 14–18 years